DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2Dr. Reddy's Laboratories
02 2Aspen API
03 12care4
04 3Abacus Medicine
05 1Alvogen
06 2Chemi SpA
07 1CinnaGen
08 1Juno Pharmaceuticals Pty Ltd
09 3Medartuum
10 22ORIFARM GROUP AS
11 1Omnia L?kemedel Ab
12 9Paranova Pharmaceuticals Ab
13 1Pharma MT
14 1Pharmascience Inc.
15 2Sandoz B2B
16 3Synthon Pharmaceuticals
17 3Teva Pharma Australia
18 24Teva Pharmaceutical Industries
19 13Viatris
20 2World Medicine
01 1FOR SOLUTION;SUBCUTANEOUS
02 1Glatiramer 20Mg 28 Joined The Parenteral Use
03 1Glatiramer 40Mg 12 Units Parenteral Use
04 2INJ
05 10INJECTABLE;SUBCUTANEOUS
06 1Injectable
07 4Injectable Solution In Pre-Filled Syringe
08 2Injection
09 3Injection fluid, resolution in the finished filled syringe
10 1PFP
11 1Pre-filled Syringe
12 1Prefilled Syringe
13 4SOLUTION
14 2SOLUTION FOR INJECTION
15 56Solution For Injection
16 3Solution For Injection In Pre-Filled
17 3injection
18 1Blank
01 5Allowed
02 16Approved
03 2Authorised
04 4Authorized
05 1DISCN
06 28Deregistered
07 2Generic
08 2Lead Market Dossiers- Filed
09 1Originator
10 4Prescription
11 10RX
12 4Withdrawn
13 18Blank
01 1Brabio
02 7COPAXONE
03 2COPAXONE 20 mg/ml
04 1COPAXONE 40 mg/ml
05 1COPEMYL
06 1COPEMYLTRI
07 1CinnoMer
08 55Copaxone
09 1Copaxone Pen
10 1Copemyl
11 1GLATECT
12 6GLATIRAMER ACETATE
13 1GLATIRAMER ACETATE INJECTION
14 1GLATIRAMER ACETATE-TEVA
15 2GLATOPA
16 2Galtipex
17 2Glatimyl
18 1Glatira
19 2Glatiramero Viatris
20 2Glatiramyl
21 2ROGRESIF/GLATIRAMER
22 1RemurelTM
23 3Blank
01 4Australia
02 4Canada
03 2India
04 1Iran
05 6Italy
06 6Malta
07 1Netherlands
08 3Norway
09 3South Africa
10 4Spain
11 44Sweden
12 5Switzerland
13 2Turkey
14 1U.S.A
15 11USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Aspen API. More than just an API™
Regulatory Info : Authorised
Registration Country : Malta
Brand Name : Galtipex
Dosage Form : Solution For Injection
Dosage Strength : 20MG
Packaging :
Approval Date : 2018-04-30
Application Number :
Regulatory Info : Authorised
Registration Country : Malta
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Aspen API. More than just an API™
Regulatory Info : Authorised
Registration Country : Malta
Brand Name : Galtipex
Dosage Form : Solution For Injection
Dosage Strength : 40MG
Packaging :
Approval Date : 2018-04-30
Application Number :
Regulatory Info : Authorised
Registration Country : Malta
Regulatory Info : RX
Registration Country : USA
Brand Name : GLATIRAMER ACETATE
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 20MG/ML
Packaging :
Approval Date : 2025-05-07
Application Number : 208468
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GLATIRAMER ACETATE
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 40MG/ML
Packaging :
Approval Date : 2025-05-07
Application Number : 208468
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GLATOPA
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 20MG/ML
Packaging :
Approval Date : 2015-04-16
Application Number : 90218
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GLATOPA
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 40MG/ML
Packaging :
Approval Date : 2018-02-12
Application Number : 206921
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GLATIRAMER ACETATE
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 20MG/ML
Packaging :
Approval Date : 2024-09-25
Application Number : 203857
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GLATIRAMER ACETATE
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 40MG/ML
Packaging :
Approval Date : 2024-09-25
Application Number : 206873
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : COPAXONE
Dosage Form : FOR SOLUTION;SUBCUTANEOUS
Dosage Strength : 20MG/VIAL
Packaging :
Approval Date : 1996-12-20
Application Number : 20622
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : COPAXONE
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 20MG/ML
Packaging :
Approval Date : 2002-02-12
Application Number : 20622
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : COPAXONE
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 40MG/ML
Packaging :
Approval Date : 2014-01-28
Application Number : 20622
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Copaxone
Dosage Form : Glatiramer 20Mg 28 Joined The Parenteral Use
Dosage Strength : 28 SYRINGES SC 20 mg/ml 1 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Copaxone
Dosage Form : Glatiramer 40Mg 12 Units Parenteral Use
Dosage Strength : 12 SYRINGES SC 40 mg/ml 1 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Copaxone
Dosage Form : Injection fluid, resolution in the finished filled syringe
Dosage Strength : 20 mg/ml
Packaging : Finish filled syringe
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Copaxone
Dosage Form : Injection fluid, resolution in the finished filled syringe
Dosage Strength : 40 mg/ml
Packaging : Finish filled syringe
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : RX
Registration Country : USA
Brand Name : GLATIRAMER ACETATE
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 20MG/ML
Packaging :
Approval Date : 2017-10-03
Application Number : 91646
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GLATIRAMER ACETATE
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 40MG/ML
Packaging :
Approval Date : 2017-10-03
Application Number : 206936
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Norway
Brand Name : Copemyl
Dosage Form : Injection fluid, resolution in the finished filled syringe
Dosage Strength : 20 mg/ml
Packaging : Finish filled syringe
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
